» Articles » PMID: 34398259

Large Joints Are Progressively Involved in Rheumatoid Arthritis Irrespective of Rheumatoid Factor Status-results from the Early Rheumatoid Arthritis Study

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2021 Aug 16
PMID 34398259
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to examine the progression of large joint involvement from early to established RA in terms of range of movement (ROM) and time to joint surgery, according to the presence of rheumatoid factor (RF). We used a historical longitudinal cohort of early RA patients. Patients were deemed RF negative if all repeated assessments were negative. The rate of progression from normal to any loss of range of movement (ROM) from years 3 to 14 were modelled using generalized estimating equations, for elbows, wrists, hips, knees and ankle, adjusting for confounders. Time to joint surgery was analysed using multivariable Cox models. A total of 1458 patients were included (66% female, mean age 55 years) and 74% were RF-positive. The prevalence of any loss of ROM, from year 3 through to 14 was highest in the wrist followed by ankle, knee, elbow and hip. Odds of loss of ROM increased over time in all joint regions assessed, at around 7-13% per year from year 3 to 14. Time to surgery was similar according to RF-status for the wrist and ankle, but RF-positive cases had a lower hazard of surgery at the elbow (HR 0.37, 0.15-0.90), hip (HR 0.69, 0.48-0.99) and after 10 years at the knee (HR 0.41, 0.25-0.68). Large joints become progressively involved in RA, most frequently affecting the wrist followed by ankle, which is overlooked in composite disease activity indices. RF-negative and positive cases progressed similarly. Treat-to-target approaches should be followed irrespective of RF status.

Citing Articles

Clinical Features of ACPA-Negative and ACPA-Positive Variants of Rheumatoid Arthritis.

Dibrov D, Avdeeva A, Rybakova V, Demidova N, Nasonov E Dokl Biochem Biophys. 2024; 517(1):243-249.

PMID: 39002008 DOI: 10.1134/S1607672924700996.


Demographic, Clinical Profile of Rheumatoid Arthritis Patients and Their Association with Disease Severity in Ghana.

Buckman T, Sakyi S, Yeboah-Mensah K, Antwi M, Darban I, Owusu-Brenya L Int J Rheumatol. 2024; 2024:6639079.

PMID: 38249778 PMC: 10798837. DOI: 10.1155/2024/6639079.


When and how should we use imaging in individuals at risk of rheumatoid arthritis?.

Harnden K, Di Matteo A, Mankia K Front Med (Lausanne). 2022; 9:1058510.

PMID: 36507546 PMC: 9726914. DOI: 10.3389/fmed.2022.1058510.

References
1.
Grondal L, Tengstrand B, Nordmark B, Wretenberg P, Stark A . The foot: still the most important reason for walking incapacity in rheumatoid arthritis: distribution of symptomatic joints in 1,000 RA patients. Acta Orthop. 2008; 79(2):257-61. DOI: 10.1080/17453670710015067. View

2.
Orces C, del Rincon I, Abel M, Escalante A . The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis. Arthritis Rheum. 2002; 47(1):67-72. DOI: 10.1002/art1.10160. View

3.
Nikiphorou E, Sjowall C, Hannonen P, Rannio T, Sokka T . Long-term outcomes of destructive seronegative (rheumatoid) arthritis - description of four clinical cases. BMC Musculoskelet Disord. 2016; 17:246. PMC: 4891827. DOI: 10.1186/s12891-016-1067-y. View

4.
Machold K, Stamm T, Nell V, Pflugbeil S, Aletaha D, Steiner G . Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford). 2006; 46(2):342-9. DOI: 10.1093/rheumatology/kel237. View

5.
Young A, Dixey J, Williams P, Prouse P, Cox N, Kiely P . An evaluation of the strengths and weaknesses of a register of newly diagnosed rheumatoid arthritis, 1986-2010. Rheumatology (Oxford). 2010; 50(1):176-83. DOI: 10.1093/rheumatology/keq318. View